Inovio Pharmaceuticals
INO
#8898
Rank
$0.14 B
Marketcap
$2.07
Share price
2.48%
Change (1 day)
-50.36%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : $10.02 Million USD

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is $10.02 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$11.86 M-60.72%
2023-12-31$30.2 M-5.82%
2022-12-31$32.07 M-2.87%
2021-12-31$33.02 M-15.43%
2020-12-31$39.04 M-60.76%
2019-12-31$99.5 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31$12.11 M0.04%
2008-12-31$12.1 M
2003-12-31$0.33 M1504.32%
2002-12-31$0.02 M-57.1%
2001-12-31$0.04 M
2001-03-31$0.11 M-0.78%
2000-03-31$0.11 M18.38%
1999-03-31$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
$60.84 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$45.79 B 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
$0.35 B 3,423.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$41.37 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
$24.94 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA